Department of Microbiology and Physiological Systems; Graduate School of Biomedical Sciences
Amino Acids, Peptides, and Proteins | Bacteria | Bacterial Infections and Mycoses | Enzymes and Coenzymes | Immunity | Immunology of Infectious Disease | Immunopathology | Microbiology
In order to sustain a persistent infection, Mycobacterium tuberculosis (Mtb) must adapt to a changing environment that is shaped by the developing immune response. This necessity to adapt is evident in the flexibility of many aspects of Mtb metabolism, including a respiratory chain that consists of two distinct terminal cytochrome oxidase complexes. Under the conditions tested thus far, the bc1/aa3 complex appears to play a dominant role, while the alternative bd oxidase is largely redundant. However, presence of two terminal oxidases in this obligate pathogen implies that respiratory requirements might change during infection. We report that the cytochrome bd oxidase is specifically required for resisting the adaptive immune response. While the bd oxidase was dispensable for growth in resting macrophages and the establishment of infection in mice, this complex was necessary for optimal fitness after the initiation of adaptive immunity. This requirement was dependent on lymphocyte-derived interferon gamma (IFNγ), but did not involve nitrogen and oxygen radicals that are known to inhibit respiration in other contexts. Instead, we found that ΔcydA mutants were hypersusceptible to the low pH encountered in IFNγ-activated macrophages. Unlike wild type Mtb, cytochrome bd-deficient bacteria were unable to sustain a maximal oxygen consumption rate (OCR) at low pH, indicating that the remaining cytochrome bc1/aa3 complex is preferentially inhibited under acidic conditions. Consistent with this model, the potency of the cytochrome bc1/aa3 inhibitor, Q203, is dramatically enhanced at low pH. This work identifies a critical interaction between host immunity and pathogen respiration that influences both the progression of the infection and the efficacy of potential new TB drugs.
Microbiology, Mycobacterium tuberculosis, cytochrome bd oxidase, immunity
Rights and Permissions
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY 4.0 International license.
DOI of Published Version
bioRxiv 2020.08.21.260737; doi: https://doi.org/10.1101/2020.08.21.260737. Link to preprint on bioRxiv service.
Cai Y, Jaecklein E, Mackenzie J, Papavinasasundaram K, Michigan State University, Chen X, Africa Health Research Institute, Sassetti CM. (2020). Host immunity increases Mycobacterium tuberculosis reliance on cytochrome bd oxidase. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1101/2020.08.21.260737. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1771
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Amino Acids, Peptides, and Proteins Commons, Bacteria Commons, Bacterial Infections and Mycoses Commons, Enzymes and Coenzymes Commons, Immunity Commons, Immunology of Infectious Disease Commons, Immunopathology Commons, Microbiology Commons